Beta-Defensin-1 (1-36), HBD-1

Catalogue number: DEF001-P

Product Type Proteins & Peptides
Units100 µg
Application Control peptide

Synthetic human peptide ß-Defensin-1 (HBD-1): Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys(Disulfide bonds between Cys5-Cys34, Cys12-Cys27, and Cys17-Cys35).

Synthetic peptide lyophilized from acetic acid

Purification Method: Synthetic peptide lyophilized from acetic acid

Control peptide

Working Concentration: (lyophilisate)


These products are intended for in vitro research use only. They must not be used for clinical diagnostics and not for in vivo experiments in humans or animals.

1. Bensch K.W., Raida M., Mägert H.J., Schulz-Knappe P., and W.G. Forssmann. HBD-1: a novel beta -defensin from human plasma. FEBS Lett 1995, 368; 331-335. (original publication HBD-1) 2. M.J. Goldman, G.M. Anderson, E.D. Stolzenberg, U.P. Kari, M. Zasloff, and J.M. Wilson, Cell, 88, 553 (1997). (Pharmacol.; Inactivated in Cystic Fibrosis) 3. T. Hiratsuka, M. Nakazato, T. Ihi, T. Minematsu, N. Chino, T. Nakanishi, A. Shimizu, K. Kangawa, and S. Matsukura, Nephron, 85, 34 (2000). (Pharmacol.)